Screening closed for all sites and final participants being scheduled for dosing On track for top-line 6-week primary endpoint results in late Q2 LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways ...

Compass Pathways (CMPS) announced yesterday morning with earnings that as a result of changing timelines for its Phase 3 trials, it will be reducing its workforce by approximately 30%, including ...

Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025 COMP006 data will now be announced after 26-week time point, expected in ...

Results of COMPASS Pathways’ open-label study of COMP360 psilocybin treatment, alongside SSRI antidepressants, suggest that SSRIs do not interfere with the potential therapeutic effect of COMP360 The ...

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways ...

LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its ...

纽约/伦敦 - 生物技术公司 Compass Pathways plc (NASDAQ:CMPS) 周二宣布与全国性介入精神病学实践网络Radial Health, Inc.建立战略合作关系，这标志着其第七个此类合作伙伴关系。据 InvestingPro 数据显示，这家市值约6.3亿美元的生物技术公司在过去六个月内股价飙升超过101%。

Investing.com - Stifel在 Compass Pathways (NASDAQ:CMPS) 举办其COMP360裸盖菇治疗投资者活动后，重申了"买入"评级和11.00美元的目标价。目前7.82美元的股价较Stifel的目标价有41%的上涨空间，而 InvestingPro 数据显示，该股交易价接近其52周高点7.87美元，过去六个月内实现了126%的价格回报。

The company is also advancing commercial preparations for COMP360 in treatment-resistant depression (TRD), aiming to be ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...